About Prescription Digital Therapeutics
Prescription digital therapeutics are clinically validated, FDA-cleared software interventions that demonstrate safety and efficacy in randomized clinical trials to improve patient outcomes. They are designed to enhance clinical outcomes, and where clinically relevant may be combined with current treatment regimens including approved drug or device therapies. Prescription digital therapeutics usually include patient-facing applications, clinical assessment and outcomes tracking, clinician monitoring dashboards and HIPAA-compliant data storage.
About Pear Therapeutics
Pear Therapeutics is the leader in FDA-cleared prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear’s lead product, reSET®, is an FDA-cleared 12-week interval prescription therapeutic for Substance Use Disorder (SUD) to be used as an adjunct to standard, outpatient treatment. Pear’s product development pipeline includes reSET®-OTM for opioid use disorder (OUD) and additional prescription digital therapeutics in schizophrenia (ThriveTM), combat posttraumatic stress disorder (reCALLTM), general anxiety disorder (reVIVETM), pain, major depressive disorder, and insomnia, for which Pear intends to obtain FDA clearance. See our Product Pipeline for details.